Fact Sheet - CIHR Institute of Circulatory and Respiratory Health - Emerging Networks: Respiratory, Stroke, Vascular

Press Release ]

Government of Canada Funding
CIHR: $13.05 million ($4.35 million per Network)

Partner Funding
Total: $9,655,848

Canadian Respiratory Research Network partners: $3,203,000

  • Canadian Lung Association: $1,085,000
  • Boehringer Ingelheim (Canada) Ltd.: $568,000
  • AstraZeneca: $550,000
  • GSK: $550,000
  • Novartis Pharmaceuticals Canada Inc.: $250,000
  • British Columbia Lung Association: $200,000

Canadian Stroke Prevention Intervention Network partners: $4,115,348

  • Heart & Stroke Foundation: $1,000,000
  • Heart & Stroke Foundation (KT): $211,261
  • Boehringer Ingelheim (Canada) Ltd.: $1,050,000
  • Biotronik Canada Inc.: $660,540
  • University of Ottawa Heart Institute: $400,000
  • Population Health Research Institute: $250,000
  • Medtronic Inc.: $200,000
  • Hamilton Health Sciences Corporation: $193,547
  • Alberta Heart Institute: $150,000

Canadian Vascular Network partners: $2,337,500

  • Hypertension Canada: $500,000
  • Université de Montréal Interventional Cardiology: $375,000
  • HSF Canadian Partnership for Stroke Recovery: $250,000
  • Ottawa Hospital Research Institute: $250,000
  • University of Ottawa Heart Institute: $250,000
  • Cell & Tissue Therapy Network of the FRSQ: $150,000
  • Libin Cardiovascular Institute of Alberta: $125,000
  • McGill University Health Centre Research Institute: $125,000
  • University of Alberta Faculty of Medicine and Dentistry: $125,000
  • Western University Schulich School of Medicine & Dentistry: $125,000
  • McGill University Faculty of Medicine: $62,500

Total Funding: $22,705,848

Description

The Emerging Networks will bring together the best minds in the fields of respiratory research, stroke research, and vascular research. They will include a broad group of stakeholders and researchers supporting research that ranges from areas of basic discovery to clinical trials, to health systems and services as well as population health. Together, they will build a critical mass of technical and scientific expertise to enhance research innovation and impact.

The Networks will develop a co-ordinated national approach to the evaluation and resolution of specific research challenges. Moreover, they will provide a forum for sharing ideas, resources, and best practices. They will also allow Canada to attract, train, and retain the best talent in health research. Finally, through their strong leadership, the Emerging Networks will align stakeholders within their respective communities to work toward the attainment of common goals.

The ultimate goal of each Emerging Network is to translate research into practice for the benefit of Canadian patients. The Networks will generate new knowledge and bridge gaps between research and outcomes by contributing to one or more of the following: identifying key knowledge gaps; promoting national and international collaborations among scientists; accelerating the translation of biomedical discoveries into clinical applications and best practices; developing, validating, and implementing an intervention that changes a significant aspect of health practice; and evaluating outcomes to demonstrate impact.

The Emerging Networks also have an important training and career development mandate. The Networks, through targeted training programs, will ensure a strong pipeline of young, diverse, and skilled researchers across all these fields.

Canadian Respiratory Research Network
Chronic lung diseases such as COPD and asthma affect almost 15% of the entire population of Canada and they exert an enormous toll on our individual health and on our health care system. The Canadian Respiratory Research Network will work collaboratively to come up with research solutions aimed at addressing the diagnosis, treatment, and prevention of chronic lung diseases in Canada.

Canadian Stroke Prevention Intervention Network
The Canadian Stroke Prevention Intervention Network (CSPIN) seeks to develop actionable strategies that will: make Canada a global leader in clinical stroke research; ensure the sustainability of these efforts through strategies to recruit, train, support and retain clinical scientists; and, in collaboration with government and stakeholder groups, implement strategies to reduce the incidence of embolic stroke in Canada by 10% within 10 years.

Canadian Vascular Network
The Vascular Network represents Canada's first comprehensive initiative to bring researchers across disciplines together to tackle one of the most challenging health problems facing our society: devastating chronic conditions such as dementia, heart disease, stroke, kidney disease, and macular degeneration resulting from diseases of the small blood vessels. The impact of diseases associated with vascular damage is staggering, affecting more than 3.7 million Canadians, and costing the healthcare system more than $30 billion per year.

About the Canadian Institutes of Health Research:
The Canadian Institutes of Health Research (CIHR) is the Government of Canada's health research investment agency. CIHR's mission is to create new scientific knowledge and to enable its translation into improved health, more effective health services and products, and a strengthened health care system for Canadians. Composed of 13 Institutes, CIHR provides leadership and support to more than 12,600 health researchers and trainees across Canada.

About the CIHR Institute of Circulatory and Respiratory Health:
The Institute of Circulatory and Respiratory Health (ICRH) supports research into causes, mechanisms, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions associated with the heart, lung, brain (stroke), blood, blood vessels, critical care, and sleep.

About the CIHR Institute of Aging:
The Institute of Aging's (IA) fundamental goal is the advancement of knowledge in the field of aging to improve the quality of life and the health of older Canadians. The Institute supports research that promotes healthy aging and addresses causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions associated with aging.

Date modified: